Karyopharm Announces Planned Merger With Ayrmid
Karyopharm Therapeutics announced a planned merger with Ayrmid Ltd. The company says it remains focused on supporting patients and advancing its multiple myeloma programs.
Story updates
12:15:57 PM UTC
SquawkNews
Karyopharm beantragt Gläubigerschutz nach Chapter 11 für geplante Fusion mit Ayrmid Karyopharm T
12:16:19 PM UTC
SquawkNews
Karyopharm files for Chapter 11 to pursue Ayrmid merger Karyopharm Therapeutics filed for Chapte
12:16:32 PM UTC
SquawkNews
KARYOPHARM THERAPEUTICS - DEAL EXPECTED TO CLOSE IN FIRST QUARTER OF 2027